LEXX: IRB Approval Clears Way for GLP-1 Study #5
LEXX READ THE FULL LEXX RESEARCH REPORT Lexaria Bioscience Corporation (NASDAQ:LEXX) reported fiscal first quarter 2025 results along with program updates, progress in its GLP-1 trials, a capital ...
Hosted on MSN15h
What Does the Future Hold for Eli Lilly?
GLP-1 treatments such as semaglutide (under the brand names Ozempic and Wegovy) by Novo Nordisk A/S (NYSE: NVO) were likely ...
The Health Risks and Benefits of Weight-Loss Drugs
The newest weight-loss drugs, Wegovy and Zepbound, are incredibly popular. But doctors are still learning about all of the ...
Can the right pillow really help reduce sleep apnea symptoms? Yes, here's how
According to statistics by the American Association of Medicine, the disorder sleep apnea affects approximately 30 million US ...
Clinton Herald19h
TO YOUR GOOD HEALTH: Prostate cancer patient gets put under active surveillance
I am a 66-year-old white male who is active and relatively healthy. I have recently been diagnosed with prostate cancer. One ...